BLEOMYCIN SULFATE 15 UNIT VIAL
For 1 unit (EA)
Pharmacies pay
$26.45 filed
1 × $26.448 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-04-22 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part B pays
$23.12 derived
1 × $23.12 per EA, Part B limit
Medicare's price is not your price.
OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)
The spread
0.87× estimated
Medicare pays 13% less than pharmacies pay.
5 labelers share HCPCS J9040 on the CMS crosswalk, so its payment limit is an average across all their products billed under that code, not this NDC’s own price.
OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-04-22 (file of 2026-10-14, retrieved 2026-10-17) · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)
Cost-plus estimate
$35.42 estimated
$26.45 + $3.97 (15%) + $5.00 fee per fill = $35.42
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-04-22 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
BLEOMYCIN SULFATE 15 UNIT VIAL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “bleomycin” and “bleomycin sulfate”, as its NDCs’ listings variously write the nonproprietary name.
FDA gives its dosage form as “injection, powder, lyophilized, for solution” and “powder, for solution” and its route as intramuscular; intrapleural; intravenous; subcutaneous.
FDA lists 5 labelers (the companies named on the label) for its NDCs, among them Hikma Pharmaceuticals USA Inc., Hospira, Inc. and NorthStar Rx LLC.
FDA’s Established Pharmacologic Class for it is Cytoprotective Agent.
The NADAC file of 2026-10-14 prices it under 6 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $26.45 for 1 unit (EA) (1 × $26.448 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-04-22. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 4, carried forward from the previous file; 5, calculated based on package size.
The NADAC of all 6 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: those prices took effect on 2026-04-22. The file is new; the price is not.
What NADAC measures · NADAC explanation codes · Carried-forward prices
All 6 NDCs
- 00143-9240-01 · Hikma Pharmaceuticals USA Inc. · $26.448 per EA · eff. 2026-04-22 filed carried forward
- 00409-0332-20 · Hospira, Inc. · $26.448 per EA · eff. 2026-04-22 filed carried forward
- 16714-0886-01 · NorthStar Rx LLC · $26.448 per EA · eff. 2026-04-22 filed carried forward
- 61703-0332-18 · Hospira, Inc. · $26.448 per EA · eff. 2026-04-22 filed carried forward
- 63323-0136-10 · Fresenius Kabi USA, LLC · $26.448 per EA · eff. 2026-04-22 filed carried forward
- 71288-0106-10 · Meitheal Pharmaceuticals Inc. · $26.448 per EA · eff. 2026-04-22 filed carried forward
What Medicare paid
Medicare Part B’s payment limit for HCPCS J9040, for 2026-10-01 to 2026-12-31, comes to $23.12 for 1 unit (EA), or $23.12 per EA once converted to NADAC’s unit for this product.
Medicare Part B pays for a drug like this only in specific settings, such as a drug given in a clinic or doctor’s office or used with certain medical equipment; most prescriptions filled at a pharmacy are paid by Part D.
The patient’s share under Part B (coinsurance, 20% of the limit, before deductibles and other coverage) is $4.624 per 15 UNITS.
Medicare's price is not your price.
What the Part B payment limit is · Converting it to the NADAC unit · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 1 unit (EA)? Is it lower than what I would pay through my insurance?
- If you have Medicare Part B: is this drug covered for me in this setting, and what is my share?
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why does this page start at 1 unit (EA)?
- NADAC prices this product per EA, and the FDA NDC Directory lists its 6 NDCs as dosage forms “INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION”, “POWDER, FOR SOLUTION” with route “INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS”. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and none of these is one. NADAC’s EA for it may be a whole package (such as a kit, pen, syringe, vial or inhaler) or one dose inside it, and the files do not say which. So the card starts at 1 unit (EA) rather than guess how many make up a fill; change it to match your prescription.